Effect of Leu-Ile-Lys tripeptide on the activity of free radical oxidation and expression of сyclooxygenase-1 and -2 in gastric mucosa in experimental indomethacin-induced ulcer in rats

Abstract

Aim. To determine the effect of Leu-Ile-Lys tripeptide on indicators of oxidative stress and expression of cyclooxygenase-1 and -2 in the gastric mucosa on the background of experimental indomethacin-induced ulcer.

Methods. Experiments were performed on 35 male Wistar rats with a body mass of 200-250 g aged 2-3 months that were divided into 3 groups: the control group (intact rats, 8 animals), control group (simulation of indomethacin-induced gastropathy, 12 animals) experimental group (simulation of indomethacin-induced gastropathy + administration of Leu-Ile-Lys tripeptide, 15 animals). The tripeptide Leu-Ile-Lys obtained by chemical synthesis (sample purity at least 98%) was administered intragastrically daily for 7 days before the simulation of indomethacin-induced damage of the gastric mucosa in a dose of 11.5 mg/kg. The model of indomethacin-induced damage to the rodent gastric mucosa was reproduced by a single intragastric administration of indomethacin in a dose of 60 mg/kg in 1 ml of saline. In the stomach homogenate the activity of free radical oxidation was determined by conventional methods. For quantitative determination of cyclooxygenase-1, -2 in gastric homogenate the method of enzyme immunoassay was used. The concentration was determined spectrometrically by the color intensity of the samples.

Results. With a prophylactic administration of tripeptide Leu-Ile-Lys, concentration of tiobarbiturate-reactive products was normalized, total antioxidant activity increased and the activity of antioxidant enzymes decreased compared to the control group. The concentration of cyclooxygenase-2 in gastric homogenate from the experimental animals was 2.3 times lower than that of the control rats.

Conclusion. Use of Leu-Ile-Lys tripeptide in experimental indomethacin-induced gastric ulcer showed a significant decrease of oxidative damage and inflammation in the gastric mucosa.

Keywords

Leu-Ile-Lys tripeptide, indomethacin-induced gastropathy

References

[1] Lorents S.E., Zharikov A.Yu., Bobrov I.P. et al. Gastroprotective action of the peptide comlex from pig kidneys in experimental «indometacine» ulcer in rats. Sibirskiy nauchnyy meditsinskiy zhurnal. 2017; 37 (6): 5–9. (In Russ.)

[2] Лоренц С.Э., Жариков А.Ю., Бобров И.П. и др. Гастропротекторное действие пептидного комплекса из тканей свиных почек при экспериментальной «индометациновой» язве у крыс. Сибирский науч. мед. ж. 2017; 37 (6): 5–9.

[3] Lorents S.E., Zharikov A.Yu., Mazko O.N. et al. Influence of the peptide complex from pork kidneys tissues on indicators of free-radical oxidation and the expression of COX-1,2 in experimental gastropathy. Ehksperimentalʹnaya i klinicheskaya gastroehnterologiya. 2018; 154 (6): 81–85. (In Russ.)

[4] Лоренц С.Э., Жариков А.Ю., Мазко О.Н. и др. Влияние пептидного комплекса из тканей свиных почек на показатели свободнорадикального окисления и экспрессию ЦОГ-1,2 при индометацин-индуцированной гастропатии. Эксперим. и клин. гастроэнтерол. 2018; 154 (6): 81–85.

[5] Zharikov A.Yu., Lorent S.E., Bobrov I.P. et al. Pharmacologically active tripeptide Leu-Ile-Lys in indome­thacin-induced gastric ulcer. Intern. J. Biomed. 2018; 8 (4): 351–354. DOI: 10.21103/Article8(4)_OA17.

[6] Shcherbatykh A.V., Kulinskiy V.I., Bolʹshe­shapov A.A., Sokolova S.V. Lipid peroxydation and antioxydative system in peptic ulcer desease and postgastroresection syndrome. Sibirskiy nauchnyy meditsinskiy zhurnal. 2005; (3): 9–13. (In Russ.)

[7] Щербатых А.В., Кулинский В.И., Большешапов А.А., Соколова С.В. Перекисное окисление ­липидов и антиоксидантная система при язвенной болезни желудка, двенадцатиперстной кишки и постгастрорезекционных синдромах. Сибирский науч. мед. ж. 2005; (3): 9–13.

[8] Demir S., Yilmaz M., Köseoğlu M. et al. Role of free radicals in peptic ulcer and gastritis. Turk. J. Gastroen­erol. 2003; 14 (1): 39–43. PMID: 14593536.

[9] Krylova S.G., Turetskova V.F., Makarova O.G. et al. Comparative study of antiulcer activity of dry aspen bark extracts in different dosage forms. Tikhookeanskiy medi­tsinskiy zhurnal. 2015; 2 (60): 18–21. (In Russ.)

[10] Крылова С.Г., Турецкова В.Ф., Макарова О.Г. и др. Сравнительное исследование противоязвенной активности экстракта коры осины сухого в различных лекарственных формах. Тихоокеанский мед. ж. 2015; 2 (60): 18–21.

[11] Turetskova V.F., Makarova O.G., Talykova N.M. et al. A method for obtaining a medication with an anti-ulcer effect. Patent for ­invention RUS 2533228. Bulletin №32 issued on 20.11.2014. (In Russ.)

[12] Турецкова В.Ф., Макарова О.Г., Талыкова Н.М. и др. Способ получения средства, обладающего противоязвенным действием. Патент на изобретение RUS 2533228. Бюлл. №32 от 20.11.2014.

[13] Bryukhanov V.M., Zverev Ya.F., Lampatov V.V. et al. Metody doklinicheskogo (ehksperimentalʹnogo) issledovaniya vliyaniya lekarstvennykh sredstv na funktsiyu pochek. (Methods of preclinical (experimental) study of the effect of drugs on renal function.) Novosibirsk: Geo. 2013; 84 р. (In Russ.)

[14] Брюханов В.М., Зверев Я.Ф., Лампатов В.В. и др. Методы доклинического (экспериментального) исследования влияния лекарственных средств на функцию почек. Новосибирск; Гео. 2013; 84 с.

[15] Khafizʹyanova R.Kh., Burykin I.M., Ale­eva G.N. Mate­maticheskaya statistika v ehksperimentalʹnoy i klini­cheskoy farmakologii. (Mathematical statistics in expe­rimental and clinical pharmacology.) Kazanʹ: Meditsina. 2006; 374 р. (In Russ.)

[16] Хафизьянова Р.Х., Бурыкин И.М., Алеева Г.Н. Математическая статистика в экспериментальной и клинической фармакологии. Казань: Медицина. 2006; 374 с.

[17] Gill R., Tsung A., Billiar T. Linking oxidative stress to inflammation: Toll-like receptors. Free Radical Biol. Med. 2010; 48 (9): 1121–1132. DOI: 10.1016/j.freeradbiomed.2010.01.006.

[18] Uchida K. A lipid-derived endogenous inducer of COX-2: a bridge between inflammation and oxidative stress. Mol. Cells. 2008, 25 (3): 347–351. PMID: 18483467.

RIGHTS & PERMISSIONS

Lorents S.E., Mazko E.N., Makarova O.G., Zharikov A.Y., Korenovskiy Y.V., Azarova O.V.